Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxazosin for Alcohol Use Disorder
NCT04135846Phase 2Active, not recruiting
- Sponsor
- Brown University
- Start
- Aug 2019
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing doxazosin with placebo (2 arms). Primary endpoint: Alcohol consumption at 6 weeks. Started Aug 2019; status: active, not recruiting.
02
Drugs
doxazosin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04135846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04135846.